Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.
Quick Stats
May 18, 202652.8
AI Score
HOLD0.49
Volume Ratio
May 06, 2026
Next Earnings
17
+ve Days (30d)
13
-ve Days (30d)
MIRM Stock Summary
Last updated May 18, 2026
MIRM is currently trading at $94.53, positioned above its 200-day moving average of $82.62, indicating a long-term uptrend. The stock has a 52-week range of $42.89 to $114.99.
Technical Analysis: The 50-day moving average stands at $95.94, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 44.535, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.12, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates MIRM at 52.8/100 with a HOLD recommendation.
MIRM (Mirum Pharmaceuticals, Inc. Common Stock) Indicators
Last updated May 18, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 44.535 |
| CMF (20) | -0.12 |
| ROC (10) | -9.027 |
| ADX (14) | 17.932 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 2.446 |
| AROONOSC (14) | 50.0 |
| WILLAMS %R (14) | -70.345 |
| MFI (14) | 67.798 |
MIRM Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
MIRM Price vs Max Options Open Interest
MIRM Max Change In Options Open Interest
MIRM Options - Sort by Max open Interest (near term)
18th May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
MIRM Daily Out of Money Options - Sort by Max open Interest (near term)
18th May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
MIRM Daily In the Money Options - Sort by Max open Interest (near term)
18th May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
MIRM Most Active Options by Volume(near term)
18th May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Mirum Pharmaceuticals, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
MIRM Moving Averages Analysis
Mirum Pharmaceuticals, Inc. Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on May 18, 2026
MIRM (Mirum Pharmaceuticals, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated May 18, 2026
| Days | MA |
|---|---|
| 10 | 105.63 |
| 20 | 100.38 |
| 30 | 99.16 |
| 50 | 95.94 |
| 100 | 94.75 |
| 200 | 82.62 |
MIRM Fundamental Analysis
| P/E (Forward) | 2000 |
| P/E (Trailing) | -- |
| Market Cap ($) | 6.8 billion |
| Earnings/Share ($) | -13.6 |
| Net Proft Margin (%) | -1.4024 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -16.33 |
| EPS Estimate Next Year ($) | -0.558 |
| WallStreet Target Price ($) | 146.3637 |
| Most Recent Quarter |